2026: reflecting on the last year’s research progress and looking at what’s ahead
2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much...
Learn more
October Walking Challenge 2025 raises over £88,000 for Cure Parkinson’s
Throughout October, our incredible supporters challenged themselves to walk 100km across the month to raise funds for Parkinson’s research. Over the past three years, our virtual walking challenges have gathered new and existing supporters in October to fundraise for Cure Parkinson’s in the crisp autumn…
An update to our research strategy
Every few years, we set out to review and refresh our research strategy. This document underpins everything we do at Cure Parkinson’s and provides the roadmap for how we plan to move closer to our goal: to identify curative treatments for Parkinson’s, with urgency. As…
Comedy for Cure evening raises over £9,200 for Cure Parkinson’s
On Wednesday 22 October, over £9,200 was raised at Comedy for Cure – a fundraising event that brought together a collection of powerhouse comedians, all to raise vital funds for a cure. Taking place at the Bloomsbury Theatre in London, one of our 2025 London…
The Movers & Shakers’ Parky Charter in Parliament
The Movers & Shakers podcasters have been fighting to improve the conditions of people living with Parkinson’s with The Parky Petition. The petition was debated in the UK Parliament on Monday 17 November. In July 2025, The Movers & Shakers’ relaunched Parky Petition reached over…
EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, is now recruiting
Cure Parkinson’s is excited to announce that the first multi-arm multi-stage clinical trial platform for Parkinson’s in the UK – EJS ACT-PD – is underway, with recruitment now open to people with Parkinson’s. The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD)…